Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 7, 3:29 PM ET
SCTX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $326.38M
- EPS (TTM)
- -$3.84
- Dividend yield
- None
- 52-week range
- 13.50 – 39.60
- Day range
- 15.75 – 18.16
- Volume / Avg
- 366.14K / 356.27K
- Beta
- —
- Shares outstanding
- 18.93M
- Next earnings
- Nov 11, 2026
52-week range
SCTX stock today
Scribe Therapeutics (SCTX) is trading at $17.24 on Oct 7, up 5.57% (+$0.91), versus the S&P 500's 0.26% decline. At this level, SCTX sits near the bottom of its 52-week range of $13.50 to $39.60: 56.5% below the high and 27.7% above the low. Scribe Therapeutics has posted a net loss over the last twelve months (EPS of -$3.84), so its P/E ratio is not meaningful.
Scribe Therapeutics's next earnings report is expected on Nov 11, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Scribe Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2026
Earnings
Earnings history- Next report
- Nov 11, 2026
Scribe Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SRZNSurrozen Inc. | 25.24 | -4.29% | $296.66M | vs SCTX |
| CABACabaletta Bio Inc. | 1.98 | -1.98% | $335.70M | vs SCTX |
| AGENAgenus Inc. | 7.57 | +1.00% | $341.65M | vs SCTX |
| XFORX4 Pharmaceuticals Inc. | 2.79 | +0.54% | $276.12M | vs SCTX |
| OCGNOcugen Inc. | 1.01 | -2.88% | $342.50M | vs SCTX |
| IKTInhibikase Therapeutics Inc. | 1.98 | -0.25% | $275.58M | vs SCTX |
| ARTVArtiva Biotherapeutics Inc. | 7.07 | -2.75% | $345.65M | vs SCTX |
| LXEOLexeo Therapeutics Inc. | 3.31 | +0.30% | $271.71M | vs SCTX |
Indexes, lists and sector
Largest Health Care stocks
Scribe Therapeutics stock FAQ
What is Scribe Therapeutics's stock price today?
SCTX last traded at $17.24 as of Oct 7, 3:29 PM EDT, up 5.57% on the day. Prices are delayed at least 15 minutes.
When is Scribe Therapeutics's next earnings date?
Scribe Therapeutics is expected to report earnings on Wednesday, November 11, 2026.
What is the SCTX 52-week high?
The 52-week high for SCTX is $39.60 and the 52-week low is $13.50. The stock is currently 56.5% below its high.